QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
PHASE1
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
PHASE1
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
PHASE1
The ability of chemotherapy to cure cancer, including breast cancer, has be...
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
PHASE1
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
PHASE2
This is a feasibility study to examine combination therapy with Trastuzumab...
Status
Completed
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins